Yan Xu

机构：Wuhan YZY Biopharma (China) · ORCID：0000-0001-6930-0093

发表论文 18 篇 · 总被引 407 次 · h-index 9

代表论文

A bibliometric analysis of T cell and atherosclerosis (2022 · Frontiers in Immunology · 被引 128)
A Bibliometric Analysis of Green Supply Chain Management Based on the Web of Science (WOS) Platform (2019 · Sustainability · 被引 120)
Immune-Ageing Evaluation of Peripheral T and NK Lymphocyte Subsets in Chinese Healthy Adults (2023 · Phenomics · 被引 35)
Innate and adaptive immune response in SARS-CoV-2 infection-Current perspectives (2022 · Frontiers in Immunology · 被引 33)
Ferroptosis in COVID-19-related liver injury: A potential mechanism and therapeutic target (2022 · Frontiers in Cellular and Infection Microbiology · 被引 28)
Bibliometric and visual analysis of cardiovascular diseases and COVID-19 research (2022 · Frontiers in Public Health · 被引 20)